Главная
Study mode:
on
1
Intro
2
Gastroesophageal Reflux: Treatment
3
Gastroesophageal Reflux: Limitations of PPIS
4
Indications for Surgery: Gastointestinal Indications
5
Goals of Interventional Therapy
6
Gastroesophageal Reflux: Alternatives
7
The Treatment Gap
8
Gastroesophageal Reflux: Endoscopic Therapies
9
Endoscopic Therapies: Commercially Available
10
Transoral Incisionless Fundoplication: Esophyx
11
Radiofrequency Ablation: Stretta
12
Endoscopic Therapies: Currently Being Studied
13
Endoscopic Stapling System: MediGus SRS
14
Endoscopic Therapies: No Longer Available
15
Gastroesophageal Reflux: Surgical Options
16
Surgical Options: Nissen Fundoplication
17
Surgical Options: Toupet Fundoplication
18
Fundoplication Versus Medical Management
19
Surgical Options: LINX Magnetic Sphincter Augmentation FDA PMA approved March 2012
20
Mechanism of Action
21
LINX: Overview
22
LINX: Reduction in Esophageal Acid Exposure
23
LINX: Discontinuation of PPI Use
24
LINX: Patient Satisfaction
25
LINX: Side Effects
26
LINX: Treatment Efficacy
Description:
Explore new treatment options for gastroesophageal reflux disease (GERD) beyond proton pump inhibitors (PPIs) in this informative lecture by Dr. David C. Chen from UCLA Digestive Disease. Delve into the limitations of PPIs, indications for surgery, and goals of interventional therapy. Discover various alternatives for GERD treatment, including endoscopic therapies like Transoral Incisionless Fundoplication (EsophyX) and Radiofrequency Ablation (Stretta). Learn about surgical options such as Nissen and Toupet Fundoplication, and gain insights into the LINX Magnetic Sphincter Augmentation device. Understand the mechanism of action, efficacy, and potential side effects of these treatments, as well as their impact on patient satisfaction and PPI usage discontinuation.

New Options for Treating GERD – Beyond PPIs - David C. Chen, MD - UCLA Digestive Disease

University of California, Los Angeles
Add to list
0:00 / 0:00